Established in 2011 Imanova was formed in an innovative alliance between the UK's Medical Research Council, Imperial College London, King's College London and University College London. In August 2017 the company was acquired by Invicro to expand its world-leading imaging services.

Imanova owns and manages the renowned Clinical Imaging Centre - a state-of-the-art facility developed by GlaxoSmithKline in 2007. The centre boosts industry-leading facilities built at a cost of over £47m. Imanova’s ongoing investment in facilities and equipment ensure that the company remains at the vanguard of imaging sciences.

GlaxoSmithKline was instrumental in the formation of Imanova, working closely with the company's partner organisations (the MRC, Imperial College London, King's College London and UCL) to establish the partnership. As well as transferring the facility into Imanova's ownership, GlaxoSmithKline provided specialist staff, imaging expertise and equipment developed at the Clinical Imaging Centre since 2007.